Pregnancy and Cardiac Prosthetic Valves

  • Jose Niz-Ramos
  • Carlos Ibarra-Perez
  • Alberto Alvarado-Duran
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)

Abstract

Female patients with significant abnormalities of one or more of the heart valves had, until few years ago, a poor life expectancy, and their possibility of reproduction was severely curtailed. Currently, those women may have a relatively normal life if they undergo replacement of the diseased valve(s) with implantation of a prosthetic cardiac valve, and they may recover the possibility of reproducing. However, a number of problems pertinent to implantation and maintenance of prosthetic valves constitute a serious risk of increased morbidity and mortality for the patient or her conceptus. It may well be stated that this circumstance encompasses new pathologic entities that must be confronted and solved by the obstetrician, anesthesiologist, and neonatologist.

Keywords

Cage Heparin Warfarin Thrombocytopenia Cardiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Memorias de las Jornadas del V aniversario del Hospital de Enfermedades del Torax. Centro Medico Nacional IMSS, 1976.Google Scholar
  2. 2.
    Palacios-Macedo J. Personal communication, 1987.Google Scholar
  3. 3.
    Harrison E, Roschke J. Pregnancy in patients with cardiac valve prostheses. Clin Obstet Gynaecol 1975;18:107–123.CrossRefGoogle Scholar
  4. 4.
    Hirsch J, Cade JF, O’Sullivan E. Clinical experience with anticoagulant therapy during pregnancy. Br Med J 1970;1:270–273.CrossRefGoogle Scholar
  5. 5.
    Hirsch J, Cade J, Gallus A. Anticoagulants in pregnancy: a review of indications and complications. Am Heart J 1972;83:301–305.CrossRefGoogle Scholar
  6. 6.
    Raivo K, Ikonen E, Saarikoski A. Fetal risk due to warfarin therapy during pregnancy. Acta Pediatr Scand 1977;66:735–739.CrossRefGoogle Scholar
  7. 7.
    Hall J, Pauli R, Wilson K. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–140.PubMedCrossRefGoogle Scholar
  8. 8.
    Bleyer W, Hakami N, Shepard T. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971;79:838–853.PubMedCrossRefGoogle Scholar
  9. 9.
    Bloomfield D. Fetal deaths and malformations associated with the use of coumarin derivatives in pregnancy. Am J Obstet Gynecol 1970;107:888–892.Google Scholar
  10. 10.
    Salazar E, Zacarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anti-coagulants, and pregnancy. Circulation 1984;70(suppl I):169–177.Google Scholar
  11. 11.
    Lutz DJ, Spittell JA Jr, Danielson GK, Fish CR. Pregnancy and its complications following cardiac valve prostheses. Am J Obstet Gynecol 1978;131:234–237.Google Scholar
  12. 12.
    Primidor B, Murray K, McAllen P. The management of anticoagulant therapy during and after pregnancy. Br J Obstet Gynaecol 1975;82:740–743.CrossRefGoogle Scholar
  13. 13.
    O’Neill H, Blake S, Sugrue D. Problems in the management of a patient with artificial valves during pregnancy. Br J Obstet Gynaecol 1982;89:940–943.PubMedCrossRefGoogle Scholar
  14. 14.
    Matorras R, Reque J, Uzandizaga J. Prosthetic heart valve and pregnancy: a study of 59 cases. Gynecol Obstet Invest 1985;19:21–26.PubMedCrossRefGoogle Scholar
  15. 15.
    Tamari I, Eldear M, Rabinowitz B. Medical treatment of cardiovascular disorders during pregnancy. Am Heart J 1982;104:1357–1361.PubMedCrossRefGoogle Scholar
  16. 16.
    Otterson W, McGranahan G, Fremman M. Successful pregnancy with McGovern aortic prostheses and long term heparin therapy. Obstet Gynecol 1968;31:273–278.PubMedCrossRefGoogle Scholar
  17. 17.
    Muller M, Lebherz T. Antepartum thrombophlebitis: morbidity with long term heparin and proposed regimen therapy. Obstet Gynecol 1969;34:874–878.Google Scholar
  18. 18.
    Gervin A. Complications of heparin therapy. Surg Gynecol Obstet 1975;140:789–792.PubMedGoogle Scholar
  19. 19.
    Letsky EA, de Swiet M. Thromboembolism in pregnancy and its management. Br J Haematol 1984;57:543–552.PubMedGoogle Scholar
  20. 20.
    Casanegra P, Aviles G, Maturana G. Cardiovascular management of pregnant women with a heart valve prostheses. Am J Cardiol 1975;36:802–804.PubMedCrossRefGoogle Scholar
  21. 21.
    Ahmad R, Rajah SM, Mearhs AJ. Dipyridamole in successful management of pregnant woman with prosthetic heart valve. Lancet 1976;2:1414–1416.PubMedCrossRefGoogle Scholar
  22. 22.
    Sangines A, Escalante M, Cervantes F. Protesis cardiaca y embarazo: revision de 10 casos. Ginecol Obstet Mex 1981;49:109–112.Google Scholar
  23. 23.
    Ibarra-Perez C, Arevalo-Toledo N, Alvarez de la Cadena O, Noriega-Guerra L. The course of pregnancy in patients with artificial heart valves. Am J Med 1976;61:504–512.PubMedCrossRefGoogle Scholar
  24. 24.
    Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl Med 1986;315:1390–1393.CrossRefGoogle Scholar
  25. 25.
    Buxbaum A, Aygen MM, Shahin W, et al. Pregnancy in patients with prosthetic heart valves. Chest 1971;59:639–642.PubMedCrossRefGoogle Scholar
  26. 26.
    Cade J, Hirsch J, Martin M. Placental barrier to coagulation factors, its relevance to the coagulation defect at birth and haemorrahage in the newborn. Br Med J 1969;2:281–286.PubMedCrossRefGoogle Scholar
  27. 27.
    Lee PK, Wang RCY, Chow JSF, et al. Adjusted subcutaneous heparin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1985;5:543–552.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • Jose Niz-Ramos
  • Carlos Ibarra-Perez
  • Alberto Alvarado-Duran

There are no affiliations available

Personalised recommendations